Siu-Yuan Huang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Siu-Yuan Huang has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
- Albert Bai
Department of Research Support, Kaiser Permanente, 3280 E Foothill Blvd, Pasadena, CA 91107, USA
1 shared publication - Anna M. Leung
Department of General Surgery, Kaiser Permanente Los Angeles Medical Center, 4867 W Sunset Blvd., Los Angeles, CA 90027, USA
1 shared publication - Antoine Lyonel Md Carré
Division of Plastic Surgery, Department of Surgery, City of Hope, Duarte, CA 92618, USA
1 shared publication - Joanie Chung
Department of Research & Evaluation Kaiser Permanente Southern California Pasadena California USA
1 shared publication - Kyuseok Im
Department of General Surgery, Kaiser Permanente Los Angeles Medical Center, Los Angeles, CA, United States
1 shared publication - Mediget Teshome
Department of Surgery, UCLA David Geffen School of Medicine, Los Angeles, USA
1 shared publication
Latest Publications
- 26 June 2026
- Published by Springer Nature in Current Breast Cancer Reports
- Vol. 18 (1) , 35
Universal Genetic Testing in Breast Cancer: A Review of the Current Landscape
- 26 June 2026
- Published by Springer Nature in Current Breast Cancer Reports
- Vol. 18 (1) , 35
Universal Genetic Testing in Breast Cancer: A Review of the Current Landscape
- Open Access
- 14 April 2025
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 14 (8) , 2682
Factors Affecting Implant Salvage in Patients with Complications After Post-Mastectomy Implant-Based Reconstruction
Background: Implant-based reconstruction (IBR) is the most common method of breast reconstruction, but complications lead to patient distress and delays in cancer treatment. Management of implant complications is varied with no defined guidelines. The inability to salvage IBR is associated with infection, but the impact of antibiotics remains controversial. We aimed to analyze factors affecting salvage rates of threatened IBR requiring operative intervention. The primary outcomes were the rates of unplanned re-operation for threatened IBR for wound closure, exchange, or explant. We hypothesized antibiotic administration would improve salvage rates. Methods: A retrospective review of patients undergoing mastectomy with IBR from 2012 to 2023 was performed. Threatened IBR was defined as implant exposure, infection, skin necrosis, hematoma, seroma, or wound dehiscence without implant exposure. Management options for patients with implant infection included implant removal and antibiotic treatment, antibiotic treatment alone, implant replacement, washout and implant replacement, or implant removal without a salvage attempt. Results: In total, 6901 patients underwent post-mastectomy IBR, and 184 (2.7%) patients had an unplanned re-operation. A total of 166/184 patients (90.2%) underwent explantation, and 18/184 (9.8%) patients had implant salvage. Between the explant and salvage groups, there were no differences in patient demographics, oncologic treatments, or operative characteristics. The explant group had a higher rate of infection (77.7% vs. 22.2%, p < 0.0001). There was no difference in culture positivity or antibiotic administration history. Conclusions: Implant salvage is feasible but limited by infection. Antibiotic administration does not improve salvage rates. Patient factors, oncologic treatment factors, or operative factors do not impact the ability to salvage.
- 14 April 2025
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 14 (8) , 2682
Open AccessFactors Affecting Implant Salvage in Patients with Complications After Post-Mastectomy Implant-Based Reconstruction
Background: Implant-based reconstruction (IBR) is the most common method of breast reconstruction, but complications lead to patient distress and delays in cancer treatment. Management of implant complications is varied with no defined guidelines. The inability to salvage IBR is associated with infection, but the impact of antibiotics remains controversial. We aimed to analyze factors affecting salvage rates of threatened IBR requiring operative intervention. The primary outcomes were the rates of unplanned re-operation for threatened IBR for wound closure, exchange, or explant. We hypothesized antibiotic administration would improve salvage rates. Methods: A retrospective review of patients undergoing mastectomy with IBR from 2012 to 2023 was performed. Threatened IBR was defined as implant exposure, infection, skin necrosis, hematoma, seroma, or wound dehiscence without implant exposure. Management options for patients with implant infection included implant removal and antibiotic treatment, antibiotic treatment alone, implant replacement, washout and implant replacement, or implant removal without a salvage attempt. Results: In total, 6901 patients underwent post-mastectomy IBR, and 184 (2.7%) patients had an unplanned re-operation. A total of 166/184 patients (90.2%) underwent explantation, and 18/184 (9.8%) patients had implant salvage. Between the explant and salvage groups, there were no differences in patient demographics, oncologic treatments, or operative characteristics. The explant group had a higher rate of infection (77.7% vs. 22.2%, p < 0.0001). There was no difference in culture positivity or antibiotic administration history. Conclusions: Implant salvage is feasible but limited by infection. Antibiotic administration does not improve salvage rates. Patient factors, oncologic treatment factors, or operative factors do not impact the ability to salvage.